Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

WuXi STA, a WuXi AppTec company

Advertisement

Articles by WuXi STA, a WuXi AppTec company

Integrated Preformulation Studies for Fast Advancement of Drug Candidates to Human Clinical Studies

ByWuXi STA, a WuXi AppTec company
June 24th 2020

Sponsored Content

Screening for developability and solubility issues Assessing pH and food effect when evaluating bioavailability Addressing solubility challenges

Advertisement

Latest Updated Articles

  • Integrated Preformulation Studies for Fast Advancement of Drug Candidates to Human Clinical Studies
    Integrated Preformulation Studies for Fast Advancement of Drug Candidates to Human Clinical Studies

    June 24th 2020



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

PharmTech Weekly Roundup—August 14, 2026

2

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

3

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

4

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

5

Engineering High-Speed Pen Injector Pre-Assembly Machine: Overcoming Dimensional Variability in Multi-Component Mechanism Integration

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us